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Abstract
Chimeric proteins boast widespread use in areas ranging from cell biology to drug delivery. Post-translational protein fusion
using the bacterial transpeptidase sortase A provides an attractive alternative when traditional gene fusion fails. We
describe use of this enzyme for in vitro protein ligation and report the successful fusion of 10 pairs of protein domains with
preserved functionality — demonstrating the robust and facile nature of this reaction.
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Introduction
The ability to incorporate disparate modular domains within
multi-functional chimeric proteins has revolutionized both the
basic and applied biological sciences. While genetic fusion remains
the gold-standard for chimera production, a given pair of protein
domains may fail to express in tandem either in reasonable yield,
or with proper folding and function—thereby limiting the diversity
of domains that can be combined. Fusion protein expression can
be particularly difficult when working with recombinant proteins
originating from different hosts.
Post-translational protein fusion would allow native expression
of the individual fusion partners—permitting expression of each
domain in the optimum host, as well as allowing modular pairing
and assembly of component domains after expression—effectively
circumventing the diversity-limiting cloning steps of tandem
genetic fusion. A number of systems for protein-protein fusion
have been explored, including native chemical ligation [1], intein
and enzyme based strategies [2,3], and residue specific chemistries
relying on cysteines or unnatural amino acids [4]. Unfortunately,
these solutions tend to be technically challenging, residue rather
than site specific, or necessitate the inclusion of large additional
protein domains to mediate fusion.
Staphylococcal Sortase A is a bacterial transpeptidase that
covalently attaches proteins to the bacterial cell wall by cleaving
between threonine and glycine at an LPXTG recognition motif to
generate an acyl-enzyme intermediate which then reacts with an
N-terminal glycine, regenerating a native amide bond [5,6]. This
chemistry has been increasingly exploited to site-specifically link
proteins displaying the C-terminal LPETGXn motif to a range of
substituents possessing a glycine or aminomethylene motif [7],
including fluorophores [8,9], photoaffinity probes [8], peptide
nucleic acids [10], sugars [11], polymers [12], solid supports
[12,13,14], lipids [15,16], microsperes [16,17], and enzymes
utilized in enzyme-linked immunosorbent assays (ELISA) [18].
Conjugation of green fluorescent protein (GFP) to cell surfaces [9]
and to make GFP multimers has been demonstrated under
reducing conditions [7,12]. Additional use as a means to
circularize proteins [19] and in domain-specific NMR [20],
demonstrates the wide range of sortase-catalyzed reactions. These
reports, as well as recent reviews [21,22,23], reveal the broad
applicability of sortase A catalyzed addition reactions, and
motivated further study of its use and optimization in producing
complex fusion proteins.
Materials and Methods
Protein Expression and Purification
Sortase-His6 enzyme was expressed essentially as described
previously [12]. Briefly, BL21 E. coli (Invitrogen, Carlsbad, CA)
transformed with pHTT27 [24] (a gift of Dr. Olaf Schneewind,
University of Chicago) were induced with 1 mM isopropyl-ß-D-1-
thiogalactopyranoside (IPTG) for 4 hours after reaching an OD600
of 0.4. Cytosolic proteins were extracted with B-per reagent
(Pierce, Rockford, IL) from pelleted cells that had been frozen
overnight. Sortase was purified from lysate using Talon resin
(Clontech, Mountain View, CA), and buffer exchanged into
50 mM Tris, 150 mM NaCl, pH 8 using a 10,000 MW cutoff spin
filter (Pierce, Rockford, IL).
A33 antigen extracellular domain bearing a His6 tag (A33-
LPETG-His6), and all IgG constructs were produced in HEK293
cells (Invitrogen, Carlsbad, CA) after PEI transfection with gWIZ
plasmids as described [25,26] (Genlantis, San Diego, CA)
according to the manufacturer’s instructions. Secreted IgG was
purified by Protein A chromatography (Pierce, Rockford, IL), and
His6 tagged protein by affinity chromatography using Talon resin
(Clontech, Mountainview, CA). GGG-GFP was produced in BL21
E. coli as described [12]. GGG-Gelonin, GGG-Fab, and GGG-
albumin were kind gifts from Christopher Pirie, Mike Schmidt,
and Kelly Davis Orcutt and produced in YVH10 yeast utilizing
pRS shuttle vectors as described [27,28]. All protein sequences are
described in Supporting Information S1.
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A33 antigen-LPETG-His6 and IgG-LC-LPETGGS at micro-
molar concentrations were reacted with each of the following:
GGG-GFP, GGG-Fab, GGG-IgG, GGG-gelonin, and GGG-
albumin (also at micromolar concentrations). Reactions were
allowed to proceed for 2 hours at 37uC after addition of 106
reaction buffer (50 mM Tris, 150 mM NaCl, pH 8, 60 mM
CaCl2) and 100 nM sortase enzyme.
The resulting samples were analyzed by running at 200 V on
12% bis-tris or Tris-acetate gels (Invitrogen, Carlsbad, CA)
according the manufacturer’s protocol after the addition of 46
sample dye (Invitrogen, Carlsbad, CA), as appropriate, after being
boiled for 10 min. Proteins were visualized by staining with Simply
Blue Safestain (Invitrogen, Carlsbad, CA).
For Western blots, gels were transferred onto nitrocellulose at
50 V in Invitrogen transfer buffer and blocked in 5% milk in
phosphate buffered saline with 0.1% Tween-20. An anti-human
light chain-HRP conjugate (AbD Serotec, Raleigh, NC) was used
to detect the light chain in the IgG-LC-LPETG fusions, and a
murine antibody to human A33 antigen (gift of Gerd Ritter,
Ludwig Institute, New York) and goat anti-mouse-HRP (Sigma,
St. Louis, MO) were used to detect A33 antigen before and after
sortase reaction. Bands were detected using ECL reagents (Pierce,
Rockford, IL), and where appropriate, quantified using ImageJ
(NIH, Bethesda, MD).
Functional Testing
For functional tests of the A33 binding IgG-LC-LPETGGS
fused to GFP, 1 ml of DynabeadsH Biotin Binder magnetic beads
(Dynal, Invitrogen, Carlsbad, CA) was washed twice in phosphate
buffered saline, 0.1% bovine serum albumin (PBSA), and
incubated with 250 ml of 850 nM biotinylated A33 antigen
(biotinylation reagent, Pierce, Rockford, IL) in PBSA at 4uC
overnight on a rotator. After beads were washed twice in PBSA to
remove free antigen, 10 ml of IgG-GFP sortase reaction mixture
was added to the antigen coated beads. The reaction mix and
beads were incubated overnight at 4uC on a rotator, then washed
twice before being analyzed for GFP signal by flow cytometry on a
Coulter EpicsXL (Beckman Coulter, Fullerton, CA). Bare beads
Figure 1. Schematic illustration of sortase A mediated reaction
fusing two proteins. Sortase A fuses an LPXTG recognition motif to
an N-terminal GGG motif, regenerating a native amide bond.
doi:10.1371/journal.pone.0018342.g001
Figure 2. Structures of N and C-terminal fusion partners denoting site and sequence of sortase A recognition motifs of each
domain.
doi:10.1371/journal.pone.0018342.g002
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controls, and the binding of IgG-GFP was specifically competed
using an excess of soluble antibody. Because both the IgG and
GFP are conformationally sensitive, these tests demonstrate
function and proper folding of both domains.
For functional tests of CEA (carcinoembryonic antigen) binding
IgG fused to A33 antigen, a similar protocol was followed utilizing
biotinylated CEA (antibody, Fitzgerald Industries, Concord, MA;
biotinylation, Pierce, Rockford, IL) to coat beads, and an Alexa-
488 labeled anti-A33 IgG (antibody gift of Gerd Ritter, Ludwig
Figure 3. Sortassembled products and functional testing. Nonreduced gel (A) and reduced Western blot (B) demonstrating the shift in
molecular weight of an IgG light chain-LPETGXn following fusion with 5 different triglycine partners. Fusion protein products are marked with an
asterisk. Light Chain (LC) was visualized. C) Gel demonstrating shift of A33 antigen-LPETGXn following fusion in reactions (rxn) with 5 different
triglycine partners. Fusion products are marked with an asterisk. D,E) Functional tests: fluorescence histograms of A33 IgG fused to GFP (D), and CEA
IgG fused to A33 antigen (E). Blue trace represents reaction mix, remaining traces represent bare beads (red), reaction mix without sortase enzyme
(green), and reaction mix with competitor IgG (yellow).
doi:10.1371/journal.pone.0018342.g003
Figure 4. Optimizing reaction conditions. A) Fusion protein yield in a reaction time course demonstrating maximal yield between 1 and 4 hours,
and reduced yield at prolonged reaction times. B) Product yield at varying pH demonstrating good yield at pH values between 7 and 9. C) Yield at
different temperatures, demonstrating improved yield at temperatures slightly above 37uC.
doi:10.1371/journal.pone.0018342.g004
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Carlsbad, CA) to detect A33 antigen. Binding of fusion product
was specifically competed using as excess of soluble CEA-IgG.
Equilibrium titrations of these IgG fusion proteins were
conducted as described previously [26]. Briefly, fixed LS174T
cells, expressing both A33 and CEA antigens, were incubated in
excess fusion protein at varying concentrations and detected by
flow cytometry using anti-human IgG-PE. Binding affinities were
determined and compared to those of non-fused IgGs.
Reaction Optimization
The ligation reaction was optimized using A33-LPETG-His6
and GGG-GFP. Briefly, 20 ml test reactions were conducted under
a variety of conditions. Each reaction consisted of LPETGXn and
GGG reactants, sortase A, in storage buffer (50 mM Tris,
150 mM NaCl, pH 8) and 106 reaction buffer (60 mM CaCl2
in 16 storage buffer). Reactant concentrations ranged from 5 to
50 uM, while enzyme concentrations were varied from 50 nM to
250 uM. The gradient function of a thermocycler was used to vary
reaction temperature, and reaction time was varied by removing
aliquots of a large reaction mix at set intervals, chilling to 4uC, and
adding EDTA to a final concentration of 10 mM to stop the
reaction. The resulting samples were analyzed by electrophoresis
at 200 V on 12% bis-tris or Tris-acetate gels (Invitrogen,
Carlsbad, CA) according the manufacturer’s protocol after the
addition of 46 sample dye and 106 reducing agent (Invitrogen,
Carlsbad, CA), as appropriate, before being boiled for 10 min.
The fusion product, approximate MW 70 kDa, was visualized




We describe here tractable in vitro conditions for the site-specific
assembly of diverse, multi-functional fusion proteins. Sortassembly
requires only 2 short peptide tags: a C-terminal LPETGXn tag on
one partner, usually incorporated as LPETG-His6 to facilitate
downstream separation, and a complementary N-terminal trigly-
cine (GGG) motif on the other domain (Fig. 1). These domains are
small and generally unobtrusive to protein production, yet allow
site and stoichiometric control of the fusion reaction. Furthermore,
a suite of proteins may be expressed with these tags allowing for
modular pairing of diverse domains without additional molecular
cloning effort. Figure 2 presents the structures of the protein
domains used in this study.
Testing the Diversity of Protein Domain Pairings
To assess the diversity of pairings that could be produced through
sortase-catalyzed fusion reactions, we generated GGG- and
LPETGXn derivatives of a variety of representative modular
domains, including enzymes (gelonin), antibodies (IgG, Fab),
fluorescent protein (GFP), and cell surface and blood proteins (A33
antigen and human serum albumin) (Fig. 2), produced in a range of
hosts, including E. coli, yeast, and mammalian cells. IgG fusions
(Fig. 3A,B) and A33 fusions were produced with all 5 C-terminal
fusionpartnerssuccessfully.Allreactionsyieldedfusionproteinsofthe
appropriate molecular weight with yields ranging from approximate-
ly 30–85%. Particularly important given the growing interest in
enzyme conjugated and bispecific antibody therapeutics was the
successful ligation of whole antibodies without disruption of the
associations between their heavy and light chains or constant
Figure 5. Optimizing concentrations of reactants. A) Fusion
protein yield at differing ratios of reactants indicating that high
concentrations of both reactants ought to be used. B) Gel of fusion
product demonstrating that excess of either reactant pushes reaction
toward completion.
doi:10.1371/journal.pone.0018342.g005
Figure 6. Optimizing enzyme concentrations. A) Fusion product yield in reactions with equimolar reactants, while varying the ratio of
sortase:total reactants. B) Fusion product yield with varying amounts of sortase enzyme in reactions with a 10-fold excess of triglycine reactant over
LPETG reactant.
doi:10.1371/journal.pone.0018342.g006
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with multiple LPETG motifs (Fig. 3A). These results demonstrate the
fusion of complex disulfide stabilized protein domains, and in
conjunction with the numerous pairings tested, demonstrate that
sortase A-mediated protein-protein fusion is a useful tool in the
generation of fusion proteins when conventional genetic fusion fails.
Functionality of Sortassembled Proteins
To demonstrate the preserved function of sortase-assembled
fusion proteins, magnetic beads were coated with antigen and then
incubated with reaction mixtures containing IgG-based fusion
proteins: A33 IgG fused to GFP, and CEA IgG fused to A33
antigen. The protein fused to the IgG was then detected by flow
cytometry either directly due to inherent fluorescence (detection of
GFP), or by incubation with a conformation-specific antibody-
fluorophore conjugate (detection of A33 antigen). In both cases,
high signal intensity was observed, and signal decreased in the
presence of specific competitor (Fig. 3D,E), indicating that the
conformation and functionality of both fusion partners remained
intact following sortassembly. Additionally, titrations of these
sortassembled IgG fusions demonstrated the retention of affinity of
the IgG domains (data not shown), providing further support as to
the mild nature of the sortassembly reaction.
Reaction Optimization
In order to increase the usefulness of this method, we sought
to optimize reaction conditions in order to maximize product
yield. The reaction is typically carried out in pH 8.2 buffered
Tris containing 6 mM CaCl2 and 150 mM NaCl. We system-
atically varied and optimized reaction conditions using A33
antigen as a model LPETG-containing substrate and triglycine-
GFP as its fusion partner. This optimization was done in
reaction volumes as low as 20 ml before determination of ideal
conditions to be used in large-scale reactions. Overall, the
reaction was robust and fusion product yield was high under a
broad range of conditions, permitting the stability and
sensitivities of the proteins being ligated to determine reaction
conditions rather than a narrow catalytic window. Briefly,
ligation product was maximal under slightly alkaline conditions
with high substrate concentrations in a reaction at 42uC for up
to 4 hours with dilute sortase A.
Experimentally, the optimal reaction time is between 1 and
4 hours (Fig. 4A), after which EDTA may be added to quench the
reaction. At long timepoints, a decrease in product is observed due
to a competing hydrolysis reaction in which enzyme irreversibly
hydrolyzes the LPETG motif found in both substrate and product.
For proteins with pH sensitive conformations, the pH of the
reaction may be varied between 7.0 and 9.0 while maintaining
high yields (Fig. 4B). Perhaps surprisingly, as sortase A functions
natively at 37uC, higher temperatures can produce a greater yield
of fusion product (Fig. 4C), and are recommended as long as the
proteins being fused are not thermolabile.
High concentrations of reactants favor high yields (Fig. 5A) and
the reaction may be pushed toward completion by adding an
excess of either fusion partner (Fig. 5B). At a 1:1 molar ratio of
reactants, typical fusion protein yields range from 30–65% of the
maximum theoretical yield, while with a 20-fold excess of one
reactant, the reaction can proceed to approximately 85% yield as
quantified by Western blot.
Care must be taken, however, in tailoring the concentration of
sortase enzyme, as adding excess enzyme reduces the amount of
fusion product either by inhibiting formation of the ternary
complex, or by increasing the overall rate of an irreversible
hydrolysis reaction of the LPETG motif (whether present in
reactants or ligated product), which releases LPET as a terminal
product. For equimolar fusion partners, a 0.1 molar equivalent of
enzyme gave optimal fusion product yield (Fig. 6A)—although this
fraction changes as the ratio of reactants is varied (Fig. 6B).
Similarly, this hydrolysis reaction impacts the time allowed for the
reaction to proceed. Because the LPETG motif is present in the
desired fusion product, the enzyme will continue to react with
fusion product, and over extended periods of time the irreversible
Table 1. Optimized conditions for sortassembly.
Condition Recommendation Acceptable Range
Time 1–4 hours 30 min to 12 hours
Temperature 42uC 37–48uC




Reactants Micromolar concentration nM and greater
pH 8.2 6.8–9.0
doi:10.1371/journal.pone.0018342.t001
Figure 7. Product quantification and purification. A) Western blot showing amount of unreacted LPETGXn substrate before (left) and after
(right) reaction, demonstrating an 85% yield when bands are quantified. B) Example purification demonstrating separation of unreacted A33-LPETG-
His6 and sortase-His6 enzyme from reaction mixture by nickel-based affinity chromatography.
doi:10.1371/journal.pone.0018342.g007
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product yield as all substrate and product become hydrolyzed.
Table 1 presents a summary of optimized reaction conditions.
Product Yield and Separation
In an optimized fusion reaction of A33 and GFP yields of 80%
were attained, as determined by quantitative Western blotting
(Fig. 7A). For other fusion pairs, in non-optimized reactions, yields
ranged from 8–50%, while after optimization, yields ranged from
40–85%. An average 4-fold improvement in yield was observed,
though in some reactions yield was improved as much as 7-fold.
For separation of product from reactants and enzyme, a His6 tag
can be incorporated both after the LPETG motif and on the
sortase enzyme, allowing unreacted substrate and enzyme to be
removed simply by passing over an affinity column (Fig. 7B).
Product may then be separated from the tri-glycine reactant by
methods such as size exclusion, ion exchange, or affinity
chromatography. In optimized reactions we have been able to
achieve 80% yields of fusion protein, with reagents and enzyme
undetectable after downstream separations.
Conclusion
By decoupling protein expression and fusion, and allowing
native amide bonds to be formed through inclusion of short
peptide tags with site and stoichiometric control, sortase A-
catalyzed assembly promises to increase the diversity of fusion
proteins and the ease with which they can be synthesized. The
mild and robust nature of this reaction, combined with its
scalability allows immediate practical application.
Supporting Information
Supporting Information S1 Provides the sequences including
N and C-terminal sites recognized by sortase A for all proteins
fused in this report.
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